Baker Plans Business Development Focus For Progenics Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
The company founder stepped down as CEO to make room for a more business-minded leader.
You may also be interested in...
Progenics Restructures To Become Leaner, Focus On Oncology
With an eye on efficiency, the biotech plans to shed its virology and infectious disease assets and transition to a pure-play oncology company.
Progenics Restructures To Become Leaner, Focus On Oncology
With an eye on efficiency, the biotech plans to shed its virology and infectious disease assets and transition to a pure-play oncology company.
People In The News: Tracking The Latest Industry Personnel Moves
Presidents and CEOs